— Phase 3 trial achieved its primary endpoint and all secondary endpoints with marked improvement in key indicators of disease — January 22, 2020 05:20 PM Eastern Standard Time DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP)...
NEW YORK, Jan. 22, 2020 /PRNewswire/ — By definition, an email drip campaign is a type of marketing process that entails the automated dissemination of emails. In addition to the ability to personalize messages, a drip campaign can be set to run during a...
TEL AVIV, Israel, Jan. 22, 2020 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today the completion of patient recruitment in the triple combination arm of its ongoing Phase 2a...
VANCOUVER, Jan. 22, 2020 /CNW/ – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that the final toxicology test, a Human Repeated Insult Patch Test (“HRIPT”), has successfully been completed. Sirona is...
SYDNEY, Jan 22, 2020 – (ACN Newswire) – Novotech CRO, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in terms of the numbers of studies, experienced world-class sites and investigators, and patient...
Email
Text